Assisted Reproductive Technology Market size to cross $35.5 Bn by 2026

Assisted Reproductive Technology Market size is projected to exceed USD 35.5 billion by 2026; according to a new research report by Global Market Insights, Inc.

Rising prevalence of sexually transmitted diseases, polycystic ovarian disease (PCOD) and faltering lifestyle habits contribute largely to increase in risk of infertility among women. Similarly, factors such as cystic fibrosis, genetics, and overlying chronic conditions among others lead to infertility in men. About 6.7% married women aged between 15-44 years in the U.S. are infertile, as per the Centers for Disease Control and Prevention. Thus, to combat with the growing challenge of infertility, the adoption of assisted reproductive technology (ART) is estimated to spur in the forthcoming years.


Request Sample Buy NowInquiry Before Buying


Demographic shift observed in working population to expand the demand for assisted reproductive technology

With changing demographics with respect to awareness and acceptance of ART in developing economies will influence ART market growth. Also, a significant rise in number of working women is observed in these nations, thereby leading to delayed child-bearing. Such factors will boost the adoption of ART in future, In addition, government approvals in favor of ART for women welfare in countries including India will positively impact the global assisted reproductive technology market growth.

Europe Assisted Reproductive Technology Market

Get more details on this report - Request Free Sample PDF

Rise in adoption of fresh donor cycles to assist segment growth

Fresh donor procedure segment is projected to foresee momentous 9.1% CAGR during the forecast timeframe. High success rate of the procedure using fresh donor oocytes increases the customer preference. Furthermore, fresh donor samples can be used during IVF that increases probability of child bearing in older women. Such advantages will present attractive potential for segment growth.

Browse key industry insights spread across 200 pages with 458 market data tables & 33 figures & charts from the report, Assisted Reproductive Technology Market Size By Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking), By Technology {In-Vitro Fertilization (IVF) {IVF with Intracytoplasmic Sperm Injection (ICSI), IVF without ICSI}, Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER)}, By End-Use (Hospitals, Fertility Clinics) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026in detail along with the table of contents:

Successful outcomes associated with cryopreserved embryo transfer will aid in segment expansion

In-vitro fertilization is further bifurcated as IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without ICSI. FER technology market held over 15% revenue share in 2019. Frozen embryo replacement (FER) or frozen embryo transfer (FET), involves thawing embryos that were frozen during former IVF or other related treatment, and its replacement in the uterine cavity at suitable time of the menstrual period. Increasing benefits, success and number of cycles performed using this technique will augment the segment size in foreseeable future.

Increasing investment in fertility clinics to boost ART market growth

Fertility clinics held more than USD 14 billion revenue size in 2019. Availability of specialized and advanced technology to carry out assisted reproductive procedures in fertility clinics will drive the segmental growth. Furthermore, rapidly increasing number of fertility clinics in emerging countries will influence the segmental growth.

Low birth rate in Japan to pose attractive growth potential to ART business

Japan assisted reproductive technology market held more than 25% share of the Asia Pacific assisted reproductive technology industry in 2019. The nation is facing challenges pertaining to low birth rates and late-in-life pregnancies. This has led to greater adoption of ART in the recent years. Additionally, rising number of ART and fertility centres will boost the market growth in the estimation period.

Product innovation to be the chief strategy adopted by prominent players

Some of the notable players operating in the assisted reproductive technology market share include Cooper Surgical, Cook Medical, Genea Ltd., Vitrolife AB and Laboratoire CCD among several others. Firms are focusing majorly on product development and launch along with some inorganic growth initiatives. For instance, in April 2018, CooperSurgical acquired fertility business from LifeGlobal Group. The acquisition expanded company’s product portfolio and thereby assisting generating more revenues.

Explore More on Related Topics:

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X